Scientists find new gut virus linked to colorectal cancer that could lead to earlier diagnosis

Researchers have identified a previously unknown virus found within common gut bacteria that appears to be linked to colorectal cancer. The discovery, stemming from research at the University of Southern Denmark, highlights a potential new avenue for understanding and potentially detecting this widespread disease.

A Complex Connection

The research began with an examination of Bacteroides fragilis, a bacterium already known to scientists as a common cause of anaerobic infections in humans, according to the National Institutes of Health. Interestingly, this bacterium is also found in individuals who remain healthy, creating a paradox for researchers. Dr. Flemming Damgaard noted, “It has been a paradox that we repeatedly find the same bacterium in connection with colorectal cancer, while at the same time it is a completely normal part of the gut in healthy people.”

Did You Know? Researchers analyzed data from two million Danish patients to identify those with bloodstream infections caused by Bacteroides fragilis, finding a correlation with subsequent diagnoses of colorectal cancer.

To investigate this discrepancy, the team examined whether variations within the bacterium itself might offer clues. Analyzing genetic material from patients with and without cancer, they discovered that bacteria from cancer patients were more frequently infected with specific viruses. Further analysis of nearly 900 stool samples from the U.S., Europe and Asia confirmed this link, revealing that individuals with colorectal cancer were approximately twice as likely to harbor traces of these viruses, including one previously undescribed.

Implications for Early Detection

While it remains unclear whether the virus directly causes colorectal cancer or is simply a marker of changes within the gut, the findings suggest a potential role in disease development. Researchers believe this discovery could lead to improvements in colorectal cancer screening. Preliminary analysis suggests the virus could identify around 40 percent of cancer cases.

Expert Insight: Identifying a viral component linked to a common bacterium opens the possibility of more targeted screening methods. However, it’s crucial to remember that correlation does not equal causation, and further research is needed to understand the virus’s precise role in the development of colorectal cancer.

Early detection of colorectal cancer is critical, as it can dramatically improve patient survival rates and allow for the removal of precancerous growths. Colorectal cancer is expected to cause 55,230 deaths in the U.S. This year, according to the American Cancer Society, and remains the second-most common cancer for both men and women.

Future Research Directions

Dr. Damgaard and his team are now focused on understanding how the gut tissue, the bacterium, and the virus interact. They are also investigating the presence of the virus within colorectal cancer tumors and conducting studies in mice predisposed to the disease to determine if the virus accelerates cancer development. In the short term, researchers hope to determine if the virus can be used to identify individuals at increased risk.

Frequently Asked Questions

What bacterium was initially studied in this research?

The research began with Bacteroides fragilis, a bacterium commonly found in the human gut and known to cause anaerobic infections.

Is this virus known to cause other diseases?

The source does not provide information about whether this virus causes other diseases.

How common is colorectal cancer in the United States?

Colorectal cancer is expected to result in 55,230 deaths in the U.S. This year and is the second-most common form of cancer for both men and women, according to the American Cancer Society.

As research continues to unravel the complex relationship between gut health and cancer, could this discovery lead to a new era of preventative screening and earlier diagnoses?